AU2005247668A1 - 3- `4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl! -5- (1H-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents - Google Patents

3- `4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl! -5- (1H-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents Download PDF

Info

Publication number
AU2005247668A1
AU2005247668A1 AU2005247668A AU2005247668A AU2005247668A1 AU 2005247668 A1 AU2005247668 A1 AU 2005247668A1 AU 2005247668 A AU2005247668 A AU 2005247668A AU 2005247668 A AU2005247668 A AU 2005247668A AU 2005247668 A1 AU2005247668 A1 AU 2005247668A1
Authority
AU
Australia
Prior art keywords
compound
formula
alkyl
mmol
pharmaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005247668A
Other languages
English (en)
Inventor
Michael Barry Gravestock
Folkert Reck
Fei Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0411593A external-priority patent/GB0411593D0/en
Priority claimed from GB0500054A external-priority patent/GB0500054D0/en
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2005247668A1 publication Critical patent/AU2005247668A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2005247668A 2004-05-25 2005-05-24 3- `4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl! -5- (1H-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents Abandoned AU2005247668A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0411593.7 2004-05-25
GB0411593A GB0411593D0 (en) 2004-05-25 2004-05-25 Chemical compounds
GB0500054.2 2005-01-05
GB0500054A GB0500054D0 (en) 2005-01-05 2005-01-05 Chemical compounds
PCT/GB2005/002051 WO2005116022A1 (en) 2004-05-25 2005-05-24 3- `4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl! -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents

Publications (1)

Publication Number Publication Date
AU2005247668A1 true AU2005247668A1 (en) 2005-12-08

Family

ID=34968778

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005247668A Abandoned AU2005247668A1 (en) 2004-05-25 2005-05-24 3- `4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl! -5- (1H-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents

Country Status (10)

Country Link
US (1) US20080021012A1 (enExample)
EP (1) EP1753754A1 (enExample)
JP (1) JP2008500317A (enExample)
AU (1) AU2005247668A1 (enExample)
BR (1) BRPI0511526A (enExample)
CA (1) CA2566963A1 (enExample)
IL (1) IL179349A0 (enExample)
MX (1) MXPA06013537A (enExample)
NO (1) NO20065889L (enExample)
WO (1) WO2005116022A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
EP2346858B1 (en) * 2008-10-10 2019-08-07 Merck Sharp & Dohme Corp. Methods for preparing oxazolidinones and compositions containing them
UA114068C2 (xx) 2009-02-03 2017-04-25 Кристалічні частинки (r)-3-(4-(2-(2-метилтетразол-5-іл)піридин-5-іл)-3-фторфеніл)-5-гідроксиметилоксазолідин-2-ондиводеньфосфату
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
KR101561964B1 (ko) 2013-11-15 2015-10-20 한국과학기술연구원 옥사졸리디논 화합물 및 이를 포함하는 c형 간염 예방 또는 치료용 약학 조성물
JP6864379B2 (ja) 2016-03-31 2021-04-28 オンターナル セラピューティック インコーポレイテッドOncternal Therapeutics, Inc. インドール類似体及びその使用
US11555033B2 (en) 2020-06-18 2023-01-17 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6689779B2 (en) * 2000-06-05 2004-02-10 Dong A Pharm. Co., Ltd. Oxazolidinone derivatives and a process for the preparation thereof
US7473699B2 (en) * 2002-02-28 2009-01-06 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and their use as antibacterial agents

Also Published As

Publication number Publication date
NO20065889L (no) 2007-02-20
MXPA06013537A (es) 2007-01-26
BRPI0511526A (pt) 2007-12-26
JP2008500317A (ja) 2008-01-10
IL179349A0 (en) 2007-03-08
WO2005116022A1 (en) 2005-12-08
US20080021012A1 (en) 2008-01-24
EP1753754A1 (en) 2007-02-21
CA2566963A1 (en) 2005-12-08

Similar Documents

Publication Publication Date Title
US7473699B2 (en) 3-cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and their use as antibacterial agents
CA2405349C (en) Oxazolidinone derivatives with antibiotic activity
AU2004218206A1 (en) Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents
JP2005519870A (ja) 抗菌活性をもつアリール置換オキサゾリジノン類
JP2006512352A (ja) オキサゾリジノン誘導体及び抗菌薬としてのそれらの使用
AU2005247670A1 (en) 3- {4- (pyridin-3-yl) phenyl} -5- (1H-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
AU2003209994A1 (en) Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
AU2005247663A1 (en) 3-[4-(6-{4,5-dihydroisoxazol-3-yl}pyridin-3-yl)-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents
AU2005247668A1 (en) 3- `4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl! -5- (1H-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
AU2005247671A1 (en) 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as MAO inhibitors for the treatment of bacterial infections
JP2006520775A (ja) 抗菌性オキサリジノン類
KR20070023766A (ko) 항박테리아제로서의 3-[4-{6-(치환알카노일)피리딘-3-일}-3-페닐]-5-(1h-1,2,3-트리아졸-1-일메틸)-1,3-옥사졸리딘-2-온
CN1989134A (zh) 作为抗菌剂的3-{4-(吡啶-3-基)苯基}-5-(1h-1,2,3-三唑-1-基甲基)-1,3-唑烷-2-酮类
KR20070023765A (ko) 항박테리아제로서의3-{4-(피리딘-3-일)페닐}-5-(1h-1,2,3-트리아졸-1-일메틸)-1,3-옥사졸리딘-2-온

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted